The bill H. 5486 aims to enhance the South Carolina Medicaid program by mandating the Department of Health and Human Services to conduct an annual review of medications and treatments available for chronic and rare kidney diseases. This review will assess the adequacy of current treatments and services for enrollees diagnosed with these conditions, and it will also explore the potential for adding new treatments. The department is required to solicit public input, particularly from individuals and groups knowledgeable about chronic and rare kidney diseases, to ensure a comprehensive evaluation.

Additionally, the bill stipulates that the department must submit an annual report detailing the findings of the review and any recommendations to the General Assembly. This report is to be submitted by January 15 each year, starting in 2027, and must be made publicly accessible on the department's website. The legislation is set to take effect upon the Governor's approval.

Statutes affected:
04/01/2026: 44-6-120
Latest Version: 44-6-120